Electrophoresis Market is expected to reach US$ 3.5 Billion by 2032, with a CAGR of 4.7% | FMI

 Global demand for Electrophoresis is expected to grow at a 4.7% CAGR from 2022 to 2032, with a market value of around US$ 2.2 billion in 2022. According to Future Market Insights, reagents and consumables will account for approximately 48.7% of the global market share in 2021.


Ongoing technological advancements in the medical and healthcare sector and rising demand for novel therapies and drugs, together with rising research projects allied with certain biomolecules are the key driving factors for the electrophoresis market.

Developing markets with improving healthcare infrastructure and high disposable income are expected to fuel the electrophoresis market’s expansion throughout the forecast period. In contrast, because electrophoresis takes a long time to complete, it may act as a key restraint on the market because it only allows for restricted sample analysis.

Electrophoresis market would benefit from improvements in speed, precision, and sensitivity, which would help the market expand. In addition, the growing interest in and demand for gene and DNA research will significantly boost market expansion. In addition, the rising demand for novel drugs and solutions is expected to boost growth.

Growing burden of cancer, bacterial infections, and genetic diseases, along with rising investments for electrophoresis research, increasing industry-academic collaborations, growing use of capillary electrophoresis with mass spectroscopy will augment sales.

 “Broad ranging applications of electrophoresis, growing utilization of next-generation sequencing, and rising advancements in genomics are set to propel the growth in the electrophoresis market,” says an FMI analyst.

Key Takeaways from Market Study

  • Reagents and consumables as products are expected to hold about 47.7% market value share by the end of 2032 and are expected to display a CAGR growth of 4.6% over the forecast period.
  • Pharma and biotech companies hold a higher end user segment share in terms of market share value of 26.7% in 2021, over diagnostic laboratories as end users. The shift is encouraged by the growing research activities, owing to larger funding by the government.
  • North America is slated to be the largest leading region with a value share of 32.5% at the end of the forecast period, owing to the technologically advanced medical device integration into healthcare treatment procedures, and high government healthcare spending.

Market Competition

Competitive Landscape

Key players operating in the global electrophoresis market are investing in collaborations with the academic and research institutes for growth and innovation in electrophoresis. They are also focusing on developing different automated electrophoresis systems which have integrated software for efficient use of this technique. With the increase in research and development in this field, various applications such as food safety and quality control have come into picture.

Agilent Technologies, Bio-Rad Laboratories, Inc., Helena Laboratories Corporation, Hoefer, Inc. (Harvard Biosciences), Merck KGaA, PerkinElmer Inc., SCIEX, SERVA Electrophoresis GmbH, Thermo Fisher Scientific Inc., Danaher Corporation, Shimadzu Corporation, Takara Bio, Inc., TBG Diagnostic Ltd, Cleaver Scientific, QIAGEN N.V., Eurogentic, Sebia Group, Analytik Jena, Lonza Group

For instance:

  • In September 2019, Bio-Rad Laboratories, Inc. announced the launch of the Science of Opioid Dependence Kit, which offers high school and undergraduate educators a simple hands-on DNA electrophoresis activity to teach complex genetics owing to the opioid crisis.
  • In September 2021, SCIEX announced its state-of-the-art capillary electrophoresis solution, the “BioPhase 8800 system”. The system is an advanced, novel multi-capillary system with the ability to process 8 samples at the same time, ensuring sample consistency and providing reliable and precise results.

Key Market Segments Covered in Electrophoresis Industry Research

By Product:

  • Instruments
    • Horizontal Systems
    • Vertical Systems
    • Capillary Electrophoresis Systems
    • Automatic Electrophoresis Systems
  • Reagents and Consumables
    • Gel
      • Polyacrylamide Gel Electrophoresis
      • Agarose Gel Electrophoresis
      • Others
    • Buffers & Others
  • Software

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Pharma & Biotech Companies
  • CROs and CMOs
  • Academic & Research Institutes
  • Forensic Laboratories

Comments

Post a Comment

Popular posts from this blog

Orthopedic Trauma Devices Market is projected to reach a valuation of US$ 21.2 Bn by 2033 | FMI

Image
  The net worth of the Orthopaedic Trauma Devices Market is expected to increase from US$ 10.7 billion in 2023 to more than US$ 21.2 billion by 2033. From 2023 to 2033, the orthopaedic trauma device market is expected to grow at a 7.1% CAGR . To learn more about this report @ https://www.futuremarketinsights.com/reports/orthopedic-trauma-devices-market With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Orthopedic Trauma Devices market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Orthopedic Trauma Devices market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision. Over the past decade, healthcar
Read more

Insulin Pen Market is forecasted to surpass US$ 46.9 Bn by 2031

Image
Diabetes is becoming more common as poor lifestyle choices continue to be prominent around the world. Insulin pens are a widely used method of treating diabetic individuals. Given this, Future Market Insights predicts that insulin pen sales will reach US$ 30,407 million in 2021. Insulin pens are used by diabetes patients to avoid problems including cardiovascular diseases that may arise from this lifestyle-based ailment. To overcome problems related to conventional methods of insulin administration, insulin pens make the process easier and faster. Get More Information on this Report @ https://www.futuremarketinsights.com/reports/insulin-pens-market According to the WHO, approximately 1.2 million deaths were caused due to diabetes in 2019 globally. To reduce the number of deaths or sufferings due to diabetes, the development of innovative techniques and products for the treatment and maintenance of diabetes is essential. Type 2 diabetes cases are common, but it can be prevented or de
Read more

Molecular Biology Enzymes, Kits & Reagents Market Size, Share, Growth, Forecast through 2032

Image
  According to a recent Future Market Insights report, the global Molecular Biology Enzymes, Kits & Reagents Market will grow dramatically between 2022 and 2032. By 2032, global sales of molecular biology enzymes, kits, and reagents are expected to total approximately US$ 48,476.41 million. Technological Advancements Leading to Enhanced Efficiency & Greater Precision of Molecular Biology Enzymes, Kits & Reagents The manufacturers of molecular biology enzymes, kits, and reagents have contributed significantly to technical breakthroughs by focusing on creating cutting-edge goods in an effort to diversify their product offerings. The cutting-edge items support the study procedures by providing features like increased precision and efficiency. One of the best instances of this is Thermo Fisher Scientific, Inc.’s SMART Digest Kit, which was created specifically for biopharmaceutical and proteomic applications. This kit reduces the time required for sample preparation while
Read more